Skip to main content
Livermore
Livermore
ZHEN

Boston Partners

SEC CIK
0001386060
Latest filing
Aug 4, 2026

HAE holding history

Haemonetics Corp in every 13F filed by Boston Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HAE overviewAll 13F holders of HAEFull Q2 2026 holdings

Shares (Q2 2026)
405,892
Value
$30.4M
% of portfolio
<0.1%
Quarters held
21
Since Q2 2021
Holdings of HAE by Boston Partners, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026405,892$30.4M<0.1%−150,787−27.1%ReducedHolders
Q1 2026556,679$31.4M<0.1%+234,012+72.5%AddedHolders
Q4 2025322,667$25.8M<0.1%−248,224−43.5%ReducedHolders
Q3 2025570,891$28.0M<0.1%+27,722+5.1%AddedHolders
Q2 2025543,169$40.7M<0.1%+11,738+2.2%AddedHolders
Q1 2025531,431$33.4M<0.1%−4,831−0.9%ReducedHolders
Q4 2024536,262$41.5M0.1%+115,506+27.5%AddedHolders
Q3 2024420,756$33.5M<0.1%−4,250−1.0%ReducedHolders
Q2 2024425,006$35.7M<0.1%−19,174−4.3%ReducedHolders
Q1 2024444,180$38.3M<0.1%−263,254−37.2%ReducedHolders
Q4 2023707,434$60.4M0.1%−24,168−3.3%ReducedHolders
Q3 2023731,602$65.1M0.1%−27,990−3.7%ReducedHolders
Q2 2023759,592$65.1M0.1%+95,928+14.5%AddedHolders
Q1 2023663,664$54.9M0.1%+147,440+28.6%AddedHolders
Q4 2022516,224$41.0M0.1%+216,210+72.1%AddedHolders
Q3 2022300,014$22.6M<0.1%−9,006−2.9%ReducedHolders
Q2 2022309,020$20.3M<0.1%+5,495+1.8%AddedHolders
Q1 2022303,525$19.1M<0.1%+2,937+1.0%AddedHolders
Q4 2021300,588$15.9M<0.1%−4,621−1.5%ReducedHolders
Q3 2021305,209$21.5M<0.1%−2,273−0.7%ReducedHolders
Q2 2021307,482$20.4M<0.1%+307,482NewHolders